Literature DB >> 3257876

B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus.

T Sakane1, N Suzuki, S Takada, Y Ueda, Y Murakawa, T Tsuchida, Y Yamauchi, T Kishimoto.   

Abstract

Peripheral blood B cells that were actively proliferating, those actively secreting immunoglobulin, and those expressing an early activation marker, Ba antigens, on the surfaces were quantitated in 25 patients with systemic lupus erythematosus (SLE). B cell hyperactivity was found in almost all of the SLE patients, as demonstrated by any one of these measures of B cell activity. Moreover, we observed a strong positive correlation between the degree of disease activity and the amount of spontaneous incorporation of 3H-thymidine by B cells; the magnitude of the increase in frequency of spontaneous Ig-secreting cells in peripheral blood correlated strikingly with certain clinical features in these patients. Our findings suggest that there is heterogeneity of B cell hyperactivity in individual patients with SLE and, thus, that clinical subsets of SLE can be identified on the basis of B cell hyperactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257876     DOI: 10.1002/art.1780310112

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane; E G Engleman
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.

Authors:  A Kitani; M Hara; T Hirose; M Harigai; K Suzuki; M Kawakami; Y Kawaguchi; T Hidaka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin.

Authors:  J E Hopper; W Sequeira; J Martellotto; E Papagiannes; L Perna; J L Skosey
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions.

Authors:  Paolo Casali; Mary K Crow; Shiquan Liu; Andrea Cerutti
Journal:  Autoimmunity       Date:  2004 Sep-Nov       Impact factor: 2.815

6.  Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.

Authors:  M S Atta; K L Lim; D A Ala'deen; R J Powell; I Todd
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

7.  Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).

Authors:  K Mitamura; H Kang; Y Tomita; H Hashimoto; S Sawada; T Horie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

8.  Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Determination of serum free light chains as a marker of systemic lupus flare.

Authors:  Ana Belén Rodríguez-Cambrón; Juana Jiménez-Jiménez; María Ángeles Blázquez-Cañamero; Francis Rey Pazos; Cristina Macía-Villa; María Alcalde-Villar; Paz Collado-Ramos; Félix Manuel Cabero Del Pozo; Eva Álvarez-Andrés; Ana Cruz-Valenciano
Journal:  Clin Rheumatol       Date:  2019-11-27       Impact factor: 2.980

10.  Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity.

Authors:  Joan Wither; Yong-chun Cai; Sooyeol Lim; Tamara McKenzie; Nicole Roslin; Jaime O Claudio; Glinda S Cooper; Thomas J Hudson; Andrew D Paterson; Celia M T Greenwood; Dafna Gladman; Janet Pope; Christian A Pineau; C Douglas Smith; John G Hanly; Christine Peschken; Gilles Boire; Paul R Fortin
Journal:  Arthritis Res Ther       Date:  2008-09-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.